Loading...
 

Off topic – More money to be made in TREATING cancer than PREVENTING it – NYT Dec 2015

Why Preventing Cancer Is Not the Priority in Drug Development

  • “There’s more money to be made investing in drugs that will extend cancer patients’ lives by a few months than in drugs that would prevent cancer in the first place.”
  • “Developing drugs to treat late-stage disease is usually much faster than developing drugs to treat early-stage disease or prevention, because late-stage disease is aggressive and progresses rapidly. This allows companies to see results in clinical trials more quickly, even if those results are only small improvements in survival.”
  • “Between 1973 and 2011, there were about 12,000 trials for relatively later-stage patients with a 90 percent chance of dying in five years.”
  • “but only 500 for cancer prevention, which confer the longest survival gains”

Proof of prevention takes a long time
Generally the prevention drugs – including vitamin D – would provide little or no profit to big pharma

See also VitaminDWiki

See any problem with this page? Report it to the webmaster.